RAPT Therapeutics, Inc. Contracts & Agreements
41 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (4)
- Human Resources (9)
- Real Estate (4)
- Uncategorized (11)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on August 11, 2023)
- Underwriting Agreement, dated November 17, 2022 (Filed With SEC on November 22, 2022)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 10, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on May 31, 2022)
- Securities Purchase Agreement, dated May 24, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto (Filed With SEC on May 31, 2022)
- Registration Rights Agreement, dated May 27, 2022, by and between RAPT Therapeutics, Inc. and the investor party thereto (Filed With SEC on May 31, 2022)
- Underwriting Agreement, dated June 15, 2021 (Filed With SEC on June 16, 2021)
- Description of Registrants Securities (Filed With SEC on March 30, 2020)
- Offer Letter, by and between Karen Lam and RAPT Therapeutics, Inc., dated July 10, 2019 (Filed With SEC on March 30, 2020)
- Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on March 30, 2020)
- Form of Underwriting Agreement (Filed With SEC on February 4, 2020)
- Collaboration and License Agreement, dated as of December 1, 2019, by and between Hanmi Pharmaceutical Co., LTD. and RAPT Therapeutics, Inc (Filed With SEC on February 4, 2020)
- Offer Letter by and between RAPT Therapeutics, Inc. and Rodney Young, dated as of November 11, 2019 (Filed With SEC on December 4, 2019)
- Form of Underwriting Agreement (Filed With SEC on October 22, 2019)
- Board of Directors Agreement, by and between Wendye Robbins and RAPT Therapeutics, Inc., dated October 11, 2019 (Filed With SEC on October 22, 2019)
- Form of Underwriting Agreement (Filed With SEC on July 22, 2019)
- Form of common stock certificate of RAPT Therapeutics, Inc (Filed With SEC on July 22, 2019)
- RAPT Therapeutics, Inc. 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Grant Notice under the 2019 Equity Incentive Plan (Filed With SEC on July 22, 2019)
- RAPT Therapeutics, Inc. 2019 Employee Stock Purchase Plan (Filed With SEC on July 22, 2019)
- Form of Indemnification Agreement by and between RAPT Therapeutics, Inc. and each of its directors and executive officers (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between Brian Wong and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between William Ho and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Amended and Restated Employee Offer Letter, by and between Dirk Brockstedt and RAPT Therapeutics, Inc., dated July 20, 2019 (Filed With SEC on July 22, 2019)
- Employee Offer Letter, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 17, 2016 (Filed With SEC on July 22, 2019)
- Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March 19, 2019 (Filed With SEC on July 22, 2019)
- Amendment to the Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated April 30, 2019 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between Linda Kozick and RAPT Therapeutics, Inc., dated November 15, 2016 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between Michael F. Giordano and RAPT Therapeutics, Inc., dated January 12, 2018 (Filed With SEC on July 22, 2019)
- Board of Directors Agreement, by and between William Rieflin and RAPT Therapeutics, Inc., dated June 23, 2015 (Filed With SEC on July 22, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc (Filed With SEC on July 22, 2019)
- Non-Employee Director Compensation Policy (Filed With SEC on July 22, 2019)
- Amended and Restated Investors Rights Agreement by and among RAPT Therapeutics, Inc. and certain of its stockholders, dated December 18, 2018 (Filed With SEC on July 5, 2019)
- RAPT Therapeutics, Inc. 2015 Stock Plan, as amended (Filed With SEC on July 5, 2019)
- Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2015 Stock Plan (Filed With SEC on July 5, 2019)
- First Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 29, 2015 (Filed With SEC on July 5, 2019)
- Second Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April 16, 2018 (Filed With SEC on July 5, 2019)
- Third Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated December 13, 2018 (Filed With SEC on July 5, 2019)
- Clinical Trial Collaboration and Supply Agreement, dated as of November 1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc (Filed With SEC on July 5, 2019)
- Lease, by and between HCP, Inc. and Flexus Biosciences, Inc., dated October 10, 2014 (Filed With SEC on July 5, 2019)
